Literature DB >> 19374844

Loss of melatonin signalling and its impact on circadian rhythms in mouse organs regulating blood glucose.

Eckhard Mühlbauer1, Elena Gross, Karin Labucay, Sabine Wolgast, Elmar Peschke.   

Abstract

The transmission of circadian rhythms is mediated by specific promoter sequences binding a particular circadian clock factor. The pineal hormone melatonin acts via G-protein-coupled receptors to synchronise these clock-generated circadian rhythms. The study was aimed to elucidate the possible role of melatonin as a zeitgeber for peripheral clocks in pancreas and liver. Reverse transcription polymerase chain reaction (RT-PCR) provided evidence of the simultaneous expression of the melatonin receptors MT(1) and MT(2) in mouse pancreas, liver and hypothalamus. Melatonin receptor knockout mice were analysed with respect to the clock gene- or clock-output transcripts PER1, DBP and RevErbalpha in pancreas and liver, and both the occurrence of phase shifts and amplitude changes were detected. Circadian PER1 protein expression was found to be retained in melatonin receptor double knockout mice with an increased amplitude as measured by semiquantitative Western blot analysis. Moreover, an impact of melatonin receptor deficiency on insulin transcripts, and altered regulation of insulin secretion and glucose homeostasis were monitored in the knockout animals. Insulin secretion from isolated islets of melatonin receptor MT(1), MT(2) or MT(1) and MT(2) double melatonin receptor-knockout animals was found to be increased relative to the wild type. These data support the idea that melatonin synchronises the functions of the major organs involved in blood glucose regulation and negatively acts on the insulin secretion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19374844     DOI: 10.1016/j.ejphar.2009.01.029

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  44 in total

1.  Lateralization of the central circadian pacemaker output: a test of neural control of peripheral oscillator phase.

Authors:  Carrie E Mahoney; Daniel Brewer; Mary K Costello; Judy McKinley Brewer; Eric L Bittman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-30       Impact factor: 3.619

Review 2.  Hepatoprotective actions of melatonin: possible mediation by melatonin receptors.

Authors:  Alexander M Mathes
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 3.  Nuclear receptor Rev-erbα: up, down, and all around.

Authors:  Logan J Everett; Mitchell A Lazar
Journal:  Trends Endocrinol Metab       Date:  2014-07-22       Impact factor: 12.015

Review 4.  Melatonin receptors: molecular pharmacology and signalling in the context of system bias.

Authors:  Erika Cecon; Atsuro Oishi; Ralf Jockers
Journal:  Br J Pharmacol       Date:  2017-08-17       Impact factor: 8.739

5.  Endogenous circadian system and circadian misalignment impact glucose tolerance via separate mechanisms in humans.

Authors:  Christopher J Morris; Jessica N Yang; Joanna I Garcia; Samantha Myers; Isadora Bozzi; Wei Wang; Orfeu M Buxton; Steven A Shea; Frank A J L Scheer
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

6.  Activation of Melatonin Signaling Promotes β-Cell Survival and Function.

Authors:  Safia Costes; Marti Boss; Anthony P Thomas; Aleksey V Matveyenko
Journal:  Mol Endocrinol       Date:  2015-02-19

Review 7.  Understanding melatonin receptor pharmacology: latest insights from mouse models, and their relevance to human disease.

Authors:  Gianluca Tosini; Sharon Owino; Jean-Luc Guillaume; Ralf Jockers
Journal:  Bioessays       Date:  2014-06-05       Impact factor: 4.345

Review 8.  Update on melatonin receptors: IUPHAR Review 20.

Authors:  Ralf Jockers; Philippe Delagrange; Margarita L Dubocovich; Regina P Markus; Nicolas Renault; Gianluca Tosini; Erika Cecon; Darius P Zlotos
Journal:  Br J Pharmacol       Date:  2016-08-08       Impact factor: 8.739

9.  Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects.

Authors:  Claudia Ha Ting Tam; Janice Sin Ka Ho; Ying Wang; Heung Man Lee; Vincent Kwok Lim Lam; Soren Germer; Mitchell Martin; Wing Yee So; Ronald Ching Wan Ma; Juliana Chung Ngor Chan; Maggie Chor Yin Ng
Journal:  PLoS One       Date:  2010-07-08       Impact factor: 3.240

10.  Effects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretion.

Authors:  Cheng Hu; Rong Zhang; Congrong Wang; Weihui Yu; Jingyi Lu; Xiaojing Ma; Jie Wang; Feng Jiang; Shanshan Tang; Yuqian Bao; Kunsan Xiang; Weiping Jia
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.